Literature DB >> 19434845

Validation of molecular docking programs for virtual screening against dihydropteroate synthase.

Kirk E Hevener1, Wei Zhao, David M Ball, Kerim Babaoglu, Jianjun Qi, Stephen W White, Richard E Lee.   

Abstract

Dihydropteroate synthase (DHPS) is the target of the sulfonamide class of antibiotics and has been a validated antibacterial drug target for nearly 70 years. The sulfonamides target the p-aminobenzoic acid (pABA) binding site of DHPS and interfere with folate biosynthesis and ultimately prevent bacterial replication. However, widespread bacterial resistance to these drugs has severely limited their effectiveness. This study explores the second and more highly conserved pterin binding site of DHPS as an alternative approach to developing novel antibiotics that avoid resistance. In this study, five commonly used docking programs, FlexX, Surflex, Glide, GOLD, and DOCK, and nine scoring functions, were evaluated for their ability to rank-order potential lead compounds for an extensive virtual screening study of the pterin binding site of B. anthracis DHPS. Their performance in ligand docking and scoring was judged by their ability to reproduce a known inhibitor conformation and to efficiently detect known active compounds seeded into three separate decoy sets. Two other metrics were used to assess performance; enrichment at 1% and 2% and Receiver Operating Characteristic (ROC) curves. The effectiveness of postdocking relaxation prior to rescoring and consensus scoring were also evaluated. Finally, we have developed a straightforward statistical method of including the inhibition constants of the known active compounds when analyzing enrichment results to more accurately assess scoring performance, which we call the 'sum of the sum of log rank' or SSLR. Of the docking and scoring functions evaluated, Surflex with Surflex-Score and Glide with GlideScore were the best overall performers for use in virtual screening against the DHPS target, with neither combination showing statistically significant superiority over the other in enrichment studies or pose selection. Postdocking ligand relaxation and consensus scoring did not improve overall enrichment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434845      PMCID: PMC2788795          DOI: 10.1021/ci800293n

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  47 in total

1.  Virtual screening using protein-ligand docking: avoiding artificial enrichment.

Authors:  Marcel L Verdonk; Valerio Berdini; Michael J Hartshorn; Wijnand T M Mooij; Christopher W Murray; Richard D Taylor; Paul Watson
Journal:  J Chem Inf Comput Sci       Date:  2004 May-Jun

2.  Comparative evaluation of eight docking tools for docking and virtual screening accuracy.

Authors:  Esther Kellenberger; Jordi Rodrigo; Pascal Muller; Didier Rognan
Journal:  Proteins       Date:  2004-11-01

3.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

4.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

5.  Comparative study of several algorithms for flexible ligand docking.

Authors:  Badry D Bursulaya; Maxim Totrov; Ruben Abagyan; Charles L Brooks
Journal:  J Comput Aided Mol Des       Date:  2003-11       Impact factor: 3.686

Review 6.  Comparing protein-ligand docking programs is difficult.

Authors:  Jason C Cole; Christopher W Murray; J Willem M Nissink; Richard D Taylor; Robin Taylor
Journal:  Proteins       Date:  2005-08-15

7.  Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites.

Authors:  W Welch; J Ruppert; A N Jain
Journal:  Chem Biol       Date:  1996-06

8.  Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.

Authors:  A Achari; D O Somers; J N Champness; P K Bryant; J Rosemond; D K Stammers
Journal:  Nat Struct Biol       Date:  1997-06

9.  Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design.

Authors:  Kerim Babaoglu; Jianjun Qi; Richard E Lee; Stephen W White
Journal:  Structure       Date:  2004-09       Impact factor: 5.006

10.  Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.

Authors:  O W Lever; L N Bell; C Hyman; H M McGuire; R Ferone
Journal:  J Med Chem       Date:  1986-05       Impact factor: 7.446

View more
  83 in total

1.  Are predefined decoy sets of ligand poses able to quantify scoring function accuracy?

Authors:  Oliver Korb; Tim Ten Brink; Fredrick Robin Devadoss Victor Paul Raj; Matthias Keil; Thomas E Exner
Journal:  J Comput Aided Mol Des       Date:  2012-01-10       Impact factor: 3.686

2.  Response surface methodology in docking study of small molecule BACE-1 inhibitors.

Authors:  Nima Razzaghi-Asl; Ahmad Ebadi; Najmeh Edraki; Ahmadreza Mehdipour; Sara Shahabipour; Ramin Miri
Journal:  J Mol Model       Date:  2012-05-13       Impact factor: 1.810

3.  Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.

Authors:  Ying Zhao; Dalia Hammoudeh; Wenwei Lin; Sourav Das; Mi-Kyung Yun; Zhenmei Li; Elizabeth Griffith; Taosheng Chen; Stephen W White; Richard E Lee
Journal:  Bioconjug Chem       Date:  2011-09-30       Impact factor: 4.774

4.  Fragment-based drug discovery using a multidomain, parallel MD-MM/PBSA screening protocol.

Authors:  Tian Zhu; Hyun Lee; Hao Lei; Christopher Jones; Kavankumar Patel; Michael E Johnson; Kirk E Hevener
Journal:  J Chem Inf Model       Date:  2013-03-14       Impact factor: 4.956

Review 5.  Microscopic Characterization of Membrane Transporter Function by In Silico Modeling and Simulation.

Authors:  J V Vermaas; N Trebesch; C G Mayne; S Thangapandian; M Shekhar; P Mahinthichaichan; J L Baylon; T Jiang; Y Wang; M P Muller; E Shinn; Z Zhao; P-C Wen; E Tajkhorshid
Journal:  Methods Enzymol       Date:  2016-07-11       Impact factor: 1.600

6.  Homology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor.

Authors:  Nicolas Levoin; Thierry Calmels; Stéphane Krief; Denis Danvy; Isabelle Berrebi-Bertrand; Jeanne-Marie Lecomte; Jean-Charles Schwartz; Marc Capet
Journal:  ACS Med Chem Lett       Date:  2011-02-11       Impact factor: 4.345

7.  Site of metabolism prediction on cytochrome P450 2C9: a knowledge-based docking approach.

Authors:  Akos Tarcsay; Róbert Kiss; György M Keseru
Journal:  J Comput Aided Mol Des       Date:  2010-04-02       Impact factor: 3.686

8.  Exploring 3D structure of human gonadotropin hormone receptor at antagonist state using homology modeling, molecular dynamic simulation, and cross-docking studies.

Authors:  Amirhossein Sakhteman; Minasadat Khoddami; Manica Negahdaripour; Arash Mehdizadeh; Mohsen Tatar; Younes Ghasemi
Journal:  J Mol Model       Date:  2016-08-25       Impact factor: 1.810

9.  Crystal structure of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase•dihydropteroate synthase bifunctional enzyme from Francisella tularensis.

Authors:  Charles W Pemble; Perdeep K Mehta; Smriti Mehra; Zhenmei Li; Amanda Nourse; Richard E Lee; Stephen W White
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  A statistical framework to evaluate virtual screening.

Authors:  Wei Zhao; Kirk E Hevener; Stephen W White; Richard E Lee; James M Boyett
Journal:  BMC Bioinformatics       Date:  2009-07-20       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.